Biotechnology: Still Fueling Controversy

It should have been one of the more earth-shattering admissions of the last hundred years when George W. Bush -- the former Texas oilman who steadfastly denies that oil ever played a part in our decision to invade Iraq -- announced that America was in fact "addicted to oil."

Instead, America's response was more akin to hearing one's 55-year-old effeminate bachelor uncle come out of the closet to the family at a holiday dinner: Everyone knew it already, but no one ever expected him to say it.

However, the evidence is indeed staggering. The United States of America uses more than a quarter of the world's annual oil production; the current administration is comprised of oil executives; our foreign policy apparatus consists of a reckless form of petro-diplomacy that requires us to prop up brutal regimes or overthrow unfriendly governments.

The situation has made our economic well-being so dependent on oil that even the slightest interruption to the oil supply has far-reaching ramifications, as we saw first with the removal of Iraqi oil from the world market, and then the refinery catastrophe in the wake of hurricanes Katrina and Rita.

And it seems to be getting worse. Oil refineries are producing at full capacity, supply has either peaked or is rapidly approaching the peak, even as demand is projected to grow 50 percent by 2025, spurred by the massive economic growth of China, India and Brazil.

As a result of all these factors, oil prices have increased more than 500 percent from the 1998 price of $13 a barrel. And when we consider the very real possibility of another mega-hurricane season, or a terrorist attack on the Saudi refining operation, even an oil-addicted president realizes that we need to make serious changes -- and fast -- or else we may not be around to pick up the pieces.

Enter BIO 2006, the annual convention of the Biotechnology Industry Organization, held last week in Chicago. Nearly 20,000 attendees converged on the city to hawk new technologies, hook up with investment opportunities, or pitch their city or state as the perfect destination for the burgeoning biotech and life-science sector, which, according to the Department of Commerce, will comprise 18 percent of the U.S. GDP by 2020, or nearly 3 trillion dollars.

And this year, "biofuels" -- renewable fuels made from plant materials -- were the center of attention, with biodiesel and ethanol as the industry's two leading hopes for spurring renewed interest and investment.

On the heels of Bush's "addicted to oil" speech, heading into the convention, BIO released a letter to Congress on March 13 requesting full funding for programs that would support research and development into ethanol production. This would all be made possible through the introduction of the newest scintillating field of biotechnology, known as "White" industrial biotechnology.

EuropaBio, the European equivalent of the Biotechnology Industry Organization, is advancing the cause of "White Biotechnology" with claims that it will reduce pollution and waste through using renewable organic resources and recycling waste for more efficient energy supplies.

In the March 13 release, BIO CEO Jim Greenwood said industrial biotech is a force that can "end our national addiction to oil. We need to rapidly move forward commercializing these technologies for cellulosic ethanol production, which will strengthen our energy and national security."

The timing of it all couldn't have been better, especially for an industry that has been reeling in a steady stream of bad PR in recent years. There have been serious problems with the introduction of the first two fields of biotech, "green" bio-agriculture -- genetically modified crops -- and "red" biomedical technology like stem-cell science.